Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus
Clinical trial NCT04127747 · UNKNOWN
Trial details
- NCT number
- NCT04127747
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2022-12-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.